Area of research
Pediatrics, Perinatology and Child Health · Pulmonary and Respiratory Medicine
Research interest
Research interests include Neonatal and fetal brain pathology, Neonatal Respiratory Health Research, Erythropoietin and Anemia Treatment, and Congenital Heart Disease Studies.
Dynamic fibroblast–immune interactions shape recovery after brain injury
Predictors of Death or Severe Impairment in Neonates With Hypoxic-Ischemic Encephalopathy
Neuroprotection for neonatal hypoxic–ischemic encephalopathy: A review of novel therapies evaluated in clinical studies
Genetic and Congenital Anomalies in Infants With Hypoxic-Ischemic Encephalopathy
Assessing Early Severity of Hypoxic-Ischemic Encephalopathy: The Role of Electroencephalogram Background in Addition to Sarnat Exam
How well does neonatal neuroimaging correlate with neurodevelopmental outcomes in infants with hypoxic-ischemic encephalopathy?
Neuroprotective therapies in the NICU in preterm infants: present and future (Neonatal Neurocritical Care Series)
Association of High-Dose Erythropoietin With Circulating Biomarkers and Neurodevelopmental Outcomes Among Neonates With Hypoxic Ischemic Encephalopathy
Longitudinal cerebrospinal fluid measurements show glial hypo- and hyperactivation in predementia Alzheimer’s disease
Safety of High Dose Erythropoietin Used with Therapeutic Hypothermia as Treatment for Newborn Hypoxic-Ischemic Encephalopathy: Secondary Analysis of the HEAL Randomized Controlled Trial
Evolution of the Sarnat exam and association with 2-year outcomes in infants with moderate or severe hypoxic-ischaemic encephalopathy: a secondary analysis of the HEAL Trial
Trial of Erythropoietin for Hypoxic–Ischemic Encephalopathy in Newborns
Neuroprotective therapies in the NICU in term infants: present and future
Risk of seizures in neonates with hypoxic-ischemic encephalopathy receiving hypothermia plus erythropoietin or placebo
Update on mechanisms of the pathophysiology of neonatal encephalopathy
Acute and Chronic Placental Abnormalities in a Multicenter Cohort of Newborn Infants with Hypoxic–Ischemic Encephalopathy
A new genetic strategy for targeting microglia in development and disease
Placental pathology and neonatal brain MRI in a randomized trial of erythropoietin for hypoxic–ischemic encephalopathy
High-Dose Erythropoietin for Asphyxia and Encephalopathy (HEAL): A Randomized Controlled Trial – Background, Aims, and Study Protocol
High-Dose Erythropoietin and Hypothermia for Hypoxic-Ischemic Encephalopathy: A Phase II Trial
Delayed erythropoietin therapy improves histological and behavioral outcomes after transient neonatal stroke
Growth Factors for the Treatment of Ischemic Brain Injury (Growth Factor Treatment)
Erythropoietin: a novel therapy for hypoxic–ischaemic encephalopathy?
Stem cells for neonatal stroke- the future is here
Erythropoietin Increases Neurogenesis and Oligodendrogliosis of Subventricular Zone Precursor Cells After Neonatal Stroke
Erythropoietin for Neuroprotection in Neonatal Encephalopathy: Safety and Pharmacokinetics
Effects of combination therapy using hypothermia and erythropoietin in a rat model of neonatal hypoxia–ischemia
An overview of risk factors for poor neurodevelopmental outcome associated with prematurity